vs
Side-by-side financial comparison of JOINT Corp (JYNT) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.
JOINT Corp is the larger business by last-quarter revenue ($15.2M vs $13.3M, roughly 1.1× OCULAR THERAPEUTIX, INC). JOINT Corp runs the higher net margin — 6.5% vs -488.0%, a 494.5% gap on every dollar of revenue. On growth, JOINT Corp posted the faster year-over-year revenue change (3.1% vs -22.4%). JOINT Corp produced more free cash flow last quarter ($334.7K vs $-57.1M). Over the past eight quarters, OCULAR THERAPEUTIX, INC's revenue compounded faster (-5.3% CAGR vs -28.6%).
The Joint Corp is a leading operator and franchisor of chiropractic care clinics primarily serving the U.S. market. It offers accessible, affordable routine chiropractic services, membership-based care plans, and caters to consumers seeking non-invasive musculoskeletal pain management and wellness support.
Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.
JYNT vs OCUL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.2M | $13.3M |
| Net Profit | $991.1K | $-64.7M |
| Gross Margin | 81.4% | 88.0% |
| Operating Margin | 4.9% | -526.5% |
| Net Margin | 6.5% | -488.0% |
| Revenue YoY | 3.1% | -22.4% |
| Net Profit YoY | 5510.5% | -33.6% |
| EPS (diluted) | $0.06 | $-0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.2M | $13.3M | ||
| Q3 25 | $13.4M | $14.5M | ||
| Q2 25 | $13.3M | $13.5M | ||
| Q1 25 | $13.1M | $10.7M | ||
| Q4 24 | $14.7M | $17.1M | ||
| Q3 24 | $30.2M | $15.4M | ||
| Q2 24 | $30.3M | $16.4M | ||
| Q1 24 | $29.7M | $14.8M |
| Q4 25 | $991.1K | $-64.7M | ||
| Q3 25 | $855.0K | $-69.4M | ||
| Q2 25 | $93.4K | $-67.8M | ||
| Q1 25 | $967.8K | $-64.1M | ||
| Q4 24 | $17.7K | $-48.4M | ||
| Q3 24 | $-3.2M | $-36.5M | ||
| Q2 24 | $-3.6M | $-43.8M | ||
| Q1 24 | $947.0K | $-64.8M |
| Q4 25 | 81.4% | 88.0% | ||
| Q3 25 | 80.1% | 87.8% | ||
| Q2 25 | 79.1% | 85.6% | ||
| Q1 25 | 77.3% | 88.2% | ||
| Q4 24 | 78.4% | 92.8% | ||
| Q3 24 | 90.7% | 89.9% | ||
| Q2 24 | 90.7% | 90.8% | ||
| Q1 24 | 90.9% | 91.0% |
| Q4 25 | 4.9% | -526.5% | ||
| Q3 25 | 1.2% | -472.3% | ||
| Q2 25 | -8.6% | -502.6% | ||
| Q1 25 | -5.2% | -597.5% | ||
| Q4 24 | 5.5% | -296.1% | ||
| Q3 24 | -1.6% | -298.2% | ||
| Q2 24 | -5.9% | -265.1% | ||
| Q1 24 | -1.4% | -214.0% |
| Q4 25 | 6.5% | -488.0% | ||
| Q3 25 | 6.4% | -477.3% | ||
| Q2 25 | 0.7% | -503.9% | ||
| Q1 25 | 7.4% | -598.7% | ||
| Q4 24 | 0.1% | -283.3% | ||
| Q3 24 | -10.5% | -236.6% | ||
| Q2 24 | -11.9% | -266.3% | ||
| Q1 24 | 3.2% | -438.9% |
| Q4 25 | $0.06 | $-0.27 | ||
| Q3 25 | $0.06 | $-0.38 | ||
| Q2 25 | $0.01 | $-0.39 | ||
| Q1 25 | $0.06 | $-0.38 | ||
| Q4 24 | $0.01 | $-0.25 | ||
| Q3 24 | $-0.21 | $-0.22 | ||
| Q2 24 | $-0.24 | $-0.26 | ||
| Q1 24 | $0.06 | $-0.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.6M | $737.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.1M | $654.3M |
| Total Assets | $61.0M | $808.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.6M | $737.1M | ||
| Q3 25 | $29.7M | $344.8M | ||
| Q2 25 | $29.8M | $391.1M | ||
| Q1 25 | $21.9M | $349.7M | ||
| Q4 24 | $25.1M | $392.1M | ||
| Q3 24 | $20.7M | $427.2M | ||
| Q2 24 | $17.5M | $459.7M | ||
| Q1 24 | $18.7M | $482.9M |
| Q4 25 | $15.1M | $654.3M | ||
| Q3 25 | $22.7M | $258.2M | ||
| Q2 25 | $23.2M | $305.9M | ||
| Q1 25 | $22.8M | $265.9M | ||
| Q4 24 | $20.7M | $315.3M | ||
| Q3 24 | $20.5M | $352.0M | ||
| Q2 24 | $23.2M | $377.7M | ||
| Q1 24 | $26.2M | $408.0M |
| Q4 25 | $61.0M | $808.1M | ||
| Q3 25 | $69.4M | $410.9M | ||
| Q2 25 | $73.2M | $451.3M | ||
| Q1 25 | $80.1M | $405.9M | ||
| Q4 24 | $83.2M | $457.9M | ||
| Q3 24 | $79.6M | $490.4M | ||
| Q2 24 | $82.4M | $517.1M | ||
| Q1 24 | $85.7M | $538.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $-54.2M |
| Free Cash FlowOCF − Capex | $334.7K | $-57.1M |
| FCF MarginFCF / Revenue | 2.2% | -430.9% |
| Capex IntensityCapex / Revenue | 9.9% | 21.4% |
| Cash ConversionOCF / Net Profit | 1.86× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.9M | $-216.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.8M | $-54.2M | ||
| Q3 25 | $1.8M | $-50.7M | ||
| Q2 25 | $868.6K | $-55.2M | ||
| Q1 25 | $-3.7M | $-44.7M | ||
| Q4 24 | $9.4M | $-39.4M | ||
| Q3 24 | $3.4M | $-36.6M | ||
| Q2 24 | $-973.5K | $-24.8M | ||
| Q1 24 | $2.8M | $-33.9M |
| Q4 25 | $334.7K | $-57.1M | ||
| Q3 25 | $1.5M | $-56.7M | ||
| Q2 25 | $363.6K | $-56.5M | ||
| Q1 25 | $-4.0M | $-46.6M | ||
| Q4 24 | $8.2M | $-39.6M | ||
| Q3 24 | $3.2M | $-36.6M | ||
| Q2 24 | $-1.2M | $-25.5M | ||
| Q1 24 | $2.4M | $-34.1M |
| Q4 25 | 2.2% | -430.9% | ||
| Q3 25 | 10.9% | -390.0% | ||
| Q2 25 | 2.7% | -419.7% | ||
| Q1 25 | -30.8% | -435.6% | ||
| Q4 24 | 55.9% | -232.0% | ||
| Q3 24 | 10.6% | -237.6% | ||
| Q2 24 | -4.1% | -155.4% | ||
| Q1 24 | 8.1% | -231.1% |
| Q4 25 | 9.9% | 21.4% | ||
| Q3 25 | 2.4% | 41.2% | ||
| Q2 25 | 3.8% | 9.3% | ||
| Q1 25 | 2.5% | 18.1% | ||
| Q4 24 | 8.1% | 1.2% | ||
| Q3 24 | 0.8% | 0.6% | ||
| Q2 24 | 0.9% | 4.5% | ||
| Q1 24 | 1.3% | 1.7% |
| Q4 25 | 1.86× | — | ||
| Q3 25 | 2.07× | — | ||
| Q2 25 | 9.30× | — | ||
| Q1 25 | -3.82× | — | ||
| Q4 24 | 532.98× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.97× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
JYNT
| Transferred At Point In Time | $12.8M | 84% |
| Transferred Over Time | $2.4M | 16% |
OCUL
Segment breakdown not available.
